Expression of V(1A) and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition

Small-cell lung cancer (SCLC) is a particularly aggressive cancer, which metastasises early. Despite initial sensitivity to radio- and chemo-therapy, it invariably relapses, so that the 2-year survival remains less than 5%. Neuropeptides particularly arginine vasopressin (AVP) and gastrin-releasing...

Descripción completa

Detalles Bibliográficos
Autores principales: MacKinnon, A C, Tufail-Hanif, U, Lucas, C D, Jodrell, D, Haslett, C, Sethi, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362091/
https://www.ncbi.nlm.nih.gov/pubmed/15685238
http://dx.doi.org/10.1038/sj.bjc.6602366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362091/
https://www.ncbi.nlm.nih.gov/pubmed/15685238
http://dx.doi.org/10.1038/sj.bjc.6602366

Ejemplares similares